Mr. Spoor is an established leader with nearly 30 years of combined executive, broad management, and capital markets expertise across healthcare and medical device industries.

Prior to joining Perspective Therapeutics, Mr. Spoor served as the President and CEO of KBP Biosciences, AzurRx BioPharma, and FluoroPharma Medical.  Mr Spoor has also worked as a strategy consultant at Oliver Wyman, and as an equity research analyst at JP Morgan and Credit Suisse where he covered biotechnology stocks and medical device companies. 

He started his career with a formal training in nuclear pharmacy which led to increasing commercial leadership roles in the imaging business at GE Healthcare (Amersham) in cardiology and oncology. Mr. Spoor also serves on the board of directors of Verifi Water, Inc. Mr. Spoor holds a Pharmacy degree from the University of Toronto and an MBA from Columbia Business School.